Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael A Rosenzweig
City of Hope Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- City of Hope Medical Center
Duarte, California, United States
Michael A. RosenzweigRecruiting - City of Hope at Seacliff
Huntington Beach, California, United States
Recruiting - City of Hope at Antelope Valley
Lancaster, California, United States
Recruiting - City of Hope at Long Beach Elm
Long Beach, California, United States
Recruiting - City of Hope at Newport Beach Fashion Island
Newport Beach, California, United States
Recruiting - City of Hope at South Pasadena
South Pasadena, California, United States
Recruiting - City of Hope at South Bay
Torrance, California, United States
Recruiting - City of Hope at Upland
Upland, California, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 24 Nov 2020
- Primary completion
- 14 Feb 2027
- Completion
- 14 Feb 2027
- Last update posted
- 29 May 2026
- Registered enrollment
- 29
- Registry id
- NCT04508790
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.